Search results for ' Vector'

Covid vaccine: Too early to say if booster dose needed

Covid vaccine: Too early to say if booster dose needed

Rediff.com30 Apr 2021

Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months

Yamuna water level rising but...: Delhi minister

Yamuna water level rising but...: Delhi minister

Rediff.com17 Jul 2023

Due to heavy rains in some areas of Haryana on Sunday, the water level of Yamuna rose slightly, she said.

Why India's Sun mission is called Aditya-L1

Why India's Sun mission is called Aditya-L1

Rediff.com30 Aug 2023

A satellite placed in the halo orbit around the first Lagrangian point (L1) of the Sun-Earth system has the major advantage of continuously viewing the Sun without any occultation/eclipses, the IIA said.

Yamuna continues to show rising trend, Delhi govt urges people to...

Yamuna continues to show rising trend, Delhi govt urges people to...

Rediff.com18 Jul 2023

The water level of the Yamuna reached 205.92 metres at 4 pm on Monday and remained above the danger mark of 205.33 metres, officials said.

China faces 'new Covid situation': Xi Jinping

China faces 'new Covid situation': Xi Jinping

Rediff.com26 Dec 2022

In his fresh directive, Xi said that more targeted patriotic health campaigns should be conducted as the country's COVID-19 epidemic prevention and control faces new situations and new tasks.

15 Zika virus cases so far in Kerala

15 Zika virus cases so far in Kerala

Rediff.com10 Jul 2021

Chief Minister Pinarayi Vijayan said Zika has been reported in Kerala and it was not unexpected as it is spread by the Aedes Aegypte mosquitoes, which causes dengue and Chickungunya.

'The real GDP was captured better'

'The real GDP was captured better'

Rediff.com1 Dec 2023

'Revision of the base year for both CPI and GDP are long overdue.' 'The basic data that went into the 2011-2012 series were mainly from surveys done in 2011 or earlier.' 'We have since seen the emergence of new sectors like platform-based work and online marketing.' 'The employment surveys and the consumption surveys need to reflect these adequately.'

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Rediff.com15 Aug 2022

The company said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster dose, for subjects who have been double vaccinated with the two commonly administered Covid vaccines in India.

Dengue outbreak: Central teams rushed to 9 states, UTs

Dengue outbreak: Central teams rushed to 9 states, UTs

Rediff.com3 Nov 2021

These nine states and union territories are Haryana, Kerala, Punjab, Rajasthan, Tamil Nadu, Uttar Pradesh, Uttarakhand, Delhi and Jammu and Kashmir.

Nipah mortality rate much higher than Covid, says ICMR

Nipah mortality rate much higher than Covid, says ICMR

Rediff.com16 Sep 2023

He asserted that all efforts are on to contain the spread of the virus in Kerala.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

Ransomware attacks surge over 2-fold in India in first half of 2023: Report

Ransomware attacks surge over 2-fold in India in first half of 2023: Report

Rediff.com4 Aug 2023

India saw a huge surge in ransomware and IoT cyber attacks in the first half of 2023, as criminals shifted to stealthier means of malicious activities, according to a report by SonicWall. While major economies like the US and the UK witnessed a decline in ransomware attacks, India (up 133 per cent) and Germany (52 per cent) are among the countries that saw a huge surge in such attacks, the 2023 SonicWall Mid-Year Cyber Threat Report for the January-June period stated. At the global level, a variety of other attacks have trended up, including cryptojacking (399 per cent), IoT malware (37 per cent) and encrypted threats (22 per cent), the report said.

Bad air quality may breathe fresh life into health insurance business

Bad air quality may breathe fresh life into health insurance business

Rediff.com14 Nov 2023

General insurance companies are likely to see a surge in demand for health insurance in the coming months due to falling air quality in the country. The health insurance segment has registered a strong growth after the pandemic due to higher awareness. In the first half of financial year 2023-24, the segment grew by 24.4 per cent to Rs 54,713.52 crore from Rs 43,981.54 crore in H1FY23, driving growth of the non-life insurance industry.

How the private sector chipped in for Chandrayaan-3

How the private sector chipped in for Chandrayaan-3

Rediff.com25 Aug 2023

A number of private companies have contributed to the development of ISRO's Chandrayaan-3 spacecraft which successfully landed near the south pole of the Moon on Wednesday evening.

'Despite Covid we don't care about health'

'Despite Covid we don't care about health'

Rediff.com7 Feb 2024

'The first duty of the government is to learn lessons from a bad experience and course correct. It's a pity that the government is making policy without looking at evidence and differentiating between immediate and urgent.'

Sanjiv Puri may get 2nd term as ITC CMD

Sanjiv Puri may get 2nd term as ITC CMD

Rediff.com11 Jul 2023

The resolution seeking his reappointment as chairman and managing director of the diversified conglomerate will be put to vote at the company's annual general meeting to be held on August 11, 2023, according to a notice sent to the shareholders on Tuesday. The company under Puri drove the 'ITC Next' strategy in the last four years encompassing digital acceleration, cost optimisation, investing in new growth vectors and ensuring supply chain agility, its officials said.

G20 summit: Delhi civic body makes big plans to fight dengue

G20 summit: Delhi civic body makes big plans to fight dengue

Rediff.com10 Jan 2023

Municipal authorities have envisioned a comprehensive and pro-active plan to combat dengue this year with focussed fumigation at monument sites and markets in Delhi, which will host the G20 summit in September.

Russia's COVID vaccine shows over 91% efficacy in phase 3 trial

Russia's COVID vaccine shows over 91% efficacy in phase 3 trial

Rediff.com2 Feb 2021

The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors -- recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Rediff.com8 Aug 2021

The study titled 'Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime' has been uploaded on medRxiv, a preprint server and is yet to be peer reviewed.

Mix-and-match vaccines highly effective against Covid: Study

Mix-and-match vaccines highly effective against Covid: Study

Rediff.com18 Oct 2021

'Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine for both doses,' Nordstrom said.

Serum Institute to start manufacturing Sputnik vaccine in September

Serum Institute to start manufacturing Sputnik vaccine in September

Rediff.com13 Jul 2021

The parties intend to produce over 300 million doses of the vaccine in India per year.

More Covid vaccine candidates get approval for clinical trials in India

More Covid vaccine candidates get approval for clinical trials in India

Rediff.com6 Feb 2021

Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.

China making virus deadlier than Covid in Pakistan: Report

China making virus deadlier than Covid in Pakistan: Report

Rediff.com6 Nov 2022

According to various global media reports, China is creating Covid-like pathogens in Pakistan that have the potential of causing virus contamination on a scale far higher than Covid.

India asks for $55-million funding in first call with Pandemic Fund

India asks for $55-million funding in first call with Pandemic Fund

Rediff.com30 May 2023

In a significant development, India is believed to have placed a funding request of around $55 million in its first call with the Pandemic Fund of the World Bank, sources said. The fund has been set up to finance critical investments in a bid to strengthen pandemic prevention, preparedness, and response capacities at national, regional, and global levels, with a focus on low- and middle-income countries. It was created in the aftermath of the Covid-19 global pandemic.

After strong run, retail demand feels the fatigue

After strong run, retail demand feels the fatigue

Rediff.com25 Apr 2023

The retail industry witnessed robust top-line growth for the greater part of the previous financial year, but demand has started to show signs of fatigue seen in the January-March quarter (fourth quarter, or Q4) of 2022-23 (FY23), especially in the apparel and innerwear segments. Jewellery, however, has managed to hold on to demand in the quarter. "In the discretionary space, demand moderation in urban markets is expected to impact the quick-service restaurant and apparel categories the most, while paint, luggage, and jewellery should see resilient growth," Systematic Institutional Equities observed in its preview of the sector.

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

Rediff.com6 Sep 2022

The Hyderabad-based firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no side effect or adverse reaction reported so far, company sources had said.

Nasal Covid Vaccine Available In Jan

Nasal Covid Vaccine Available In Jan

Rediff.com28 Dec 2022

The vaccine would not have production scalability issues unlike Covaxin, Bharat Biotech's COVID-19 virus vaccine.

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Rediff.com26 Jan 2023

'iNCOVACC' is priced at Rs 800 for private markets and at Rs 325 for supplies to the government of India and state governments.

'Surveillance can't go down because the curve is going down'

'Surveillance can't go down because the curve is going down'

Rediff.com29 Dec 2020

'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'

Russia eyes partnership with India for COVID-19 vaccine

Russia eyes partnership with India for COVID-19 vaccine

Rediff.com20 Aug 2020

'We believe that India is capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have'

Confused about COVID vaccines in India? This is for you

Confused about COVID vaccines in India? This is for you

Rediff.com13 Apr 2021

The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:

Centre holds high-level meet as 11 states report serotype-2 dengue cases

Centre holds high-level meet as 11 states report serotype-2 dengue cases

Rediff.com18 Sep 2021

Cabinet Secretary Rajiv Gauba chaired a high-level meet with representatives of states/UTs to also review and discussed the COVID-19 management and response strategy through video conference.

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Rediff.com24 May 2021

Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) has begun the production of 'Sputnik V' COVID-19 vaccine in India, according to a joint statement issued.

Bharat Bio's nasal Covid vaccine gets regulator nod for phase 3 trials

Bharat Bio's nasal Covid vaccine gets regulator nod for phase 3 trials

Rediff.com28 Jan 2022

India's drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated with SARS-CoV 2 vaccines.

'Sputnik V provides immunity for a longer duration'

'Sputnik V provides immunity for a longer duration'

Rediff.com26 Jul 2021

'Its efficacy is 97.6 per cent.'

COVID-19 vaccine race: Where they stand currently

COVID-19 vaccine race: Where they stand currently

Rediff.com9 Jan 2021

As India prepares to launch its vaccine drive on January 16, here is a look at the options:

Mandaviya meets Dr Reddy's Lab chief on Sputnik V production

Mandaviya meets Dr Reddy's Lab chief on Sputnik V production

Rediff.com5 Aug 2021

Dr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft launched the vaccine in India in May 2021, after receiving Emergency Use Authorisation in April 2021.

Mixing different vaccines produces better immune response: Study

Mixing different vaccines produces better immune response: Study

Rediff.com7 Dec 2021

Following up first doses of the AstraZeneca or Pfizer vaccines with second doses of the Moderna or Novavax jabs generates robust immune response against COVID-19, according to a study published in The Lancet journal.

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Rediff.com16 Sep 2020

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.

Adani is hooked on ChatGPT, says race for AI to get complex

Adani is hooked on ChatGPT, says race for AI to get complex

Rediff.com20 Jan 2023

Asia's richest man Gautam Adani, besides looking at opportunities to expand his vast empire, is hooked on ChatGPT - the programme that trawls vast amount of information to generate natural-sounding text on virtually anything - from crafting jokes to writing ad copy, debugging computer code, to even generating poems and essays. Adani, whose conglomerate has in recent years diversified from mines, ports and power plants into airports, data centres and defence, penned musing from his visit to Davos to attend the World Economic Forum meeting. "From a meetings perspective, this was perhaps my busiest WEF as I met over a dozen heads of states and several business leaders," he wrote on LinkedIn, talking of new geopolitical couplings, climate change and tight-lipped evangelists and AI.